TABLE 1.
The clinical and pathological features of the patients, stratified by age decade
Age, years | |||||
---|---|---|---|---|---|
Variable | 30–39 | 40–49 | 50–59 | 60–69 | ≥70 |
Preoperative PSA level, ng/mL | |||||
Mean (SD) | 6.8 (10.7) | 6.9 (6.7) | 7.3 (5.9) | 7.9 (7.4) | 8.8 (7.6) |
Median (range) | 4.0 (0.3–66) | 5.4 (0.2–79) | 5.8 (0.1–68) | 6.2 (0.1–151) | 7.0 (0.7–49.9) |
n (%): | |||||
Biopsy Gleason score | |||||
≤6 | 36 (85.7) | 744 (84.3) | 3242 (79.8) | 2757 (74) | 126 (70.4) |
7 | 4 (9.5) | 123 (13.9) | 697 (17.2) | 798 (21.5) | 40 (22.3) |
8–10 | 2 (4.8) | 16 (1.8) | 123 (3.0) | 166 (4.5) | 13 (7.3) |
Clinical stage | |||||
≤T1c | 26 (61.9) | 523 (58.8) | 2543 (62.3) | 2202 (58.7) | 95 (53.7) |
T2 | 16 (38.1) | 353 (39.7) | 1492 (36.6) | 1517 (40.4) | 82 (46.3) |
T3 | 0 | 13 (1.5) | 44 (1.1) | 30 (0.8) | 0 |
D0 | 0 | 0 | 0 | 2 (0.1) | 0 |
Organ-confined | 34 (81.0) | 616 (69.1) | 2654 (65.2) | 2133 (56.8) | 90 (49.7) |
Positive surgical margins | 2 (4.8) | 100 (11.2) | 536 (13.1) | 607 (16.1) | 38 (20.9) |
Capsular penetration | 8 (19.1) | 272 (30.5) | 1386 (33.9) | 1587 (42.1) | 87 (47.8) |
Seminal vesicle invasion | 1 (2.4) | 43 (4.8) | 224 (5.5) | 274 (7.3) | 21 (11.6) |
Lymph node metastases | 1 (2.4) | 32 (3.6) | 124 (3.0) | 146 (3.9) | 8 (4.4) |